Abstract
Maintenance Use Is More Important Than the Choice of Bortezomib-Based Triplet Induction in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Stem Cell Transplantation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have